article thumbnail

What to expect from PEGS Europe 2023: Day 2

Drug Discovery World

Gail Calvert, Field Application Scientist, Sartorius UK, on: ‘Leveraging integrated and advanced technologies for successful cell line development’. Jorge Dias, PhD, Principal Scientist, Alchemab Therapeutics, on: ‘A patient-first approach to discover first-in-class antibody therapeutics’.

article thumbnail

Reflecting on PEGS Europe 2023 

Drug Discovery World

It was by Nicholas Field, Principal Scientist, Purification Development, Lonza, titled: ‘Tailored CMC solutions to overcome the challenges in bispecific, Fab and Fc-fusion protein development programs’. This presentation covered three primary drivers for a protein expression model: speed, cost and sustainability. “It